Why UnitedHealth Stock Popped on Wednesday

Source The Motley Fool

Key Points

  • An analyst raised his price target on the health insurer by 14%.

  • He also kept his buy recommendation intact.

  • 10 stocks we like better than UnitedHealth Group ›

An analyst's price target increase for UnitedHealth Group (NYSE: UNH) stock was taken to heart by investors on Wednesday. Following news of the boost, they collectively pushed the large health insurer's stock up by almost 5% that trading session.

14% more optimistic

The person behind the raise was Wolfe Research prognosticator Justin Lake. Well before market open that day, he upped his price target on UnitedHealth to $375 per share from his previous $330. He maintained his outperform (i.e., buy) recommendation as he did so.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Two people participating in a telehealth session.

Image source: Getty Images.

According to reports, the analyst is bullish on the future of both the company's foundational UnitedHealthcare insurance operations and its Optum healthcare services and tech unit.

He believes that UnitedHealthcare will be able to improve its margins to meet management's target levels. Meanwhile, Optum has good potential to post meaningful growth going forward.

Looks like a buy on weakness

Collectively, analysts are modeling improvements on both the top and bottom lines for UnitedHealth's 2026. Their consensus for revenue growth that year is 2% (to just over $457 billion), while that for per-share earnings is an encouraging 9% (to $17.71).

Lake's rosy take on the stock aside, UnitedHealth hasn't been a popular stock lately. It's facing numerous challenges these days. To name two significant ones, it's coping with a surge in costs related to its Medicare Advantage business, and Affordable Care Act (i.e., Obamacare) subsidies are weeks away from expiration.

That said, the company remains a powerhouse in its sector, and I believe these problems are surmountable. Given that, I'd consider buying its stock at the current weakened price.

Should you invest $1,000 in UnitedHealth Group right now?

Before you buy stock in UnitedHealth Group, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $589,717!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,111,405!*

Now, it’s worth noting Stock Advisor’s total average return is 1,018% — a market-crushing outperformance compared to 194% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of December 1, 2025

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Silver Price Forecast: XAG/USD surges to record high above $56 amid bullish momentumSilver (XAG/USD) climbs to a fresh all-time high on Friday, buoyed by dovish Federal Reserve expectations alongside strong industrial and investment demand.
Author  FXStreet
Dec 01, Mon
Silver (XAG/USD) climbs to a fresh all-time high on Friday, buoyed by dovish Federal Reserve expectations alongside strong industrial and investment demand.
placeholder
Crypto Market Outlook: Bitcoin, Ethereum, and XRP Tumble as BoJ Hawkishness Sparks Risk-Off RoutBitcoin slides below $87,000, Ethereum leans on $2,800 support and XRP hovers around $2.00 as December opens with a risk-off tone, leaving BTC eyeing $80,600–$74,508, ETH exposed to $2,111 and XRP to $1.90 unless buyers can turn key levels into a base for a rebound.
Author  Mitrade
Dec 01, Mon
Bitcoin slides below $87,000, Ethereum leans on $2,800 support and XRP hovers around $2.00 as December opens with a risk-off tone, leaving BTC eyeing $80,600–$74,508, ETH exposed to $2,111 and XRP to $1.90 unless buyers can turn key levels into a base for a rebound.
placeholder
Australian Dollar sits near three-week top vs USD as hawkish RBA offsets weak GDPThe Australian Dollar (AUD) reverses dismal domestic data-led intraday downtick and touches a fresh three-week high against a weaker US Dollar (USD) during the Asian session on Wednesday.
Author  FXStreet
21 hours ago
The Australian Dollar (AUD) reverses dismal domestic data-led intraday downtick and touches a fresh three-week high against a weaker US Dollar (USD) during the Asian session on Wednesday.
placeholder
Fed’s $13.5B Liquidity Injection: Will it Fuel Bitcoin to $50K or Signal a Crash?The Federal Reserve injected $13.5 billion into the banking system, signaling a significant liquidity boost for Bitcoin and risk assets, rivaling levels from the COVID-19 era.
Author  Mitrade
20 hours ago
The Federal Reserve injected $13.5 billion into the banking system, signaling a significant liquidity boost for Bitcoin and risk assets, rivaling levels from the COVID-19 era.
placeholder
Solana Price Forecast: ETF Demand and Derivatives Flows Fuel a Sharper ReboundSolana (SOL) trades above $140 after a 10% daily jump, as ETF inflows flip positive, futures open interest climbs 6.75% and on-chain TVL and stablecoin liquidity rise, setting up a potential double-bottom breakout toward the 50-day EMA at $158 if SOL can secure a daily close above $145.
Author  Mitrade
17 hours ago
Solana (SOL) trades above $140 after a 10% daily jump, as ETF inflows flip positive, futures open interest climbs 6.75% and on-chain TVL and stablecoin liquidity rise, setting up a potential double-bottom breakout toward the 50-day EMA at $158 if SOL can secure a daily close above $145.
goTop
quote